Marshall Wace’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Marshall Wace’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-724,590	Closed	-$7.35M	–	3667
2022 Q3	$7.35M	Hold	724,590	–	–	0.02%	1109
2022 Q2	$7.27M	Buy	724,590 +5,607	+0.8%	+$56.3K	0.02%	1094
2022 Q1	$7.2M	Buy	718,983 +267,426	+59%	+$2.68M	0.01%	1115
2021 Q4	$4.49M	Buy	+451,557	New	+$4.48M	0.01%	1440

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Marshall Wace's ARCK Position: Q4 2022 in Review

Marshall Wace sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 724,590 shares — an estimated $7.35M sold.

Marshall Wace first reported a position in ARCK in Q4 2021 and held it in 4 quarters. The position peaked at $7.35M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Marshall Wace reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Marshall Wace sold 724,590 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $7.35M.
Marshall Wace first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q4 2021 and held it in 4 quarters.
Marshall Wace's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $7.35M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.